Skip to main content
TipRanks
Go Ultimate75% OFF

Robert J. Schott Insider Profile

4 Followers

Robert J. Schott, SVP, Head of Development at Sangamo Therapeutics, holds 75.54K shares in Sangamo Therapeutics (Ticker: SGMOQ).

Robert J. Schott's Trading History

SGMOQ
Sangamo Therapeutics
Mar 01, 2022SVP, Head of DevelopmentUninformative Buy―$8.84K
SGMOQ
Insider Shares: 75.54K (0.00%)

Robert J. Schott has not reported any informative transactions for SGMOQ, therefore, performance cannot be measured.

DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Mar 01, 2022Uninformative Buy$0.0041,000$0.00―
Feb 24, 2022Uninformative Sell$31.47K5,463$5.76―
Feb 16, 2021Uninformative Buy$0.0040,000$0.00―

You May Also Like

Robert J. Schott insider profile FAQ

What stocks does Robert J. Schott hold?
Robert J. Schott holds: SGMOQ stocks.
What is Robert J. Schott's role in Sangamo Therapeutics?
Robert J. Schott's role in Sangamo Therapeutics is SVP, Head of Development.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.